Medibank IPO: prognosis negative

This medical insurer isn't the safe stock it's made out to be and it needs more than a 4% dividend yield to attract us.

Medibank chief executive George Savvides tells a story of a tense wage negotiation with unions at the Australian arm of UK medical products company Smith & Nephew, which he was running in the 1990s. As the negotiations heated up, a shop steward told him that the issue was not so much the 4% wage claim, but the concern of low-paid workers that their families would be left unprotected if they fell ill or died.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles